| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB-DYYB | 191 |
| 1 | LENALIDOMIDE | 183 |
| 2 | INFLIXIMAB | 143 |
| 3 | CENEGERMIN-BKBJ | 92 |
| 4 | PREDNISONE | 59 |
| 5 | HUMAN IMMUNOGLOBULIN G | 58 |
| 6 | ERGOCALCIFEROL | 53 |
| 7 | ACETAMINOPHEN | 51 |
| 8 | ADALIMUMAB | 42 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMATINIB ORAL | 1 | 0.1111 |
| 1 | ANTISEPTIC SURGICAL SCRUB | 1 | 0.0667 |
| 2 | INFLIXIMAB-DYYB | 191 | 0.0554 |
| 3 | TORIPALIMAB-TPZI | 1 | 0.0233 |
| 4 | URIDINE TRIACETATE | 2 | 0.0134 |
| 5 | TEBENTAFUSP | 8 | 0.0133 |
| 6 | CIPROFLOXACIN AND DEXAMETHASONE | 1 | 0.0130 |
| 7 | CALASPARGASE PEGOL | 10 | 0.0124 |
| 8 | GARADACIMAB | 9 | 0.0117 |
| 9 | IMLUNESTRANT | 1 | 0.0109 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 337 |
| 1 | Thalidomide Analog [EPC] | 199 |
| 2 | Corticosteroid [EPC] | 139 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 107 |
| 4 | Recombinant Human Nerve Growth Factor [EPC] | 92 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 76 |
| 6 | Interleukin-23 Antagonist [EPC] | 73 |
| 7 | Human Immunoglobulin G [EPC] | 60 |
| 8 | Provitamin D2 Compound [EPC] | 53 |
| 9 | Factor Xa Inhibitor [EPC] | 46 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 8 | 0.0133 |
| 1 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 2 | Recombinant Human Nerve Growth Factor [EPC] | 92 | 0.0068 |
| 3 | Carboxypeptidase [EPC] | 2 | 0.0055 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 15 | 0.0034 |
| 5 | Human Immunoglobulin G [EPC] | 60 | 0.0028 |
| 6 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 7 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 8 | Provitamin D2 Compound [EPC] | 53 | 0.0018 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |